TUBERCULOSIS, PULMONARY, DRUG SENSITIVE

Clinical trials for TUBERCULOSIS, PULMONARY, DRUG SENSITIVE explained in plain language.

Never miss a new study

Get alerted when new TUBERCULOSIS, PULMONARY, DRUG SENSITIVE trials appear

Sign up with your email to follow new studies for TUBERCULOSIS, PULMONARY, DRUG SENSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Shorter TB regimens could simplify treatment

Disease control Not yet recruiting

This study looks at whether shorter, rifapentine-based treatments for tuberculosis and latent TB are safe and effective in real-world settings in Kazakhstan. It will follow 350 adults, including those with HIV, comparing a 4-month regimen to the standard 6-month one for active TB…

Matched conditions: TUBERCULOSIS, PULMONARY, DRUG SENSITIVE

Sponsor: Public Union "Kazakhstan Association of Phthisiopulmonologists" • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

TUBERCULOSIS, PULMONARY, DRUG SENSITIVE

Get alerted when new TUBERCULOSIS, PULMONARY, DRUG SENSITIVE trials appear

Shorter TB regimens could simplify treatment